Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 6/20 | 0.41 |
| ▸ | NOS1 | P29475 | 4/20 | 0.41 |
| ▸ | NOS3 | P29474 | 3/20 | 0.41 |
| ▸ | KIF11 | P52732 | 9/20 | 0.36 |
| ▸ | ARG1 | P05089 | 1/20 | 0.34 |
| ▸ | ARG2 | P78540 | 1/20 | 0.34 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20816349 | 1.00 | NOS2 (0.41) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL6130506 | 0.87 | NOS2 (0.39) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL20456896 | 0.84 | NOS2 (0.37) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL9326098 | 0.84 | KIF11 (0.36) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL10422578 | 0.84 | KIF11 (0.36) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL121974 | 0.84 | SMN1; SMN2 (0.34) | NOS2NOS1NOS3MEN1KMT2A | |
| SCHEMBL3921490 | 0.84 | SMN1; SMN2 (0.34) | NOS2NOS1NOS3MEN1KMT2A | |
| SCHEMBL15757119 | 0.82 | KIF11 (0.33) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL7115160 | 0.82 | KIF11 (0.33) | NOS2NOS1NOS3KIF11ARG1 | |
| SCHEMBL9810276 | 0.82 | KIF11 (0.33) | NOS2NOS1NOS3KIF11ARG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 583 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003906-A1 | PEPTIDE-LOADED CARRIER SYSTEMS AND USES THEREOF | Academia Sinica (TW) | 2022-06-01 | — | — | EP | claimed |
| WO-2021021861-A1 | PEPTIDE-LOADED CARRIER SYSTEMS AND USES THEREOF | ACADEMIA SINICA (TW) | 2021-02-04 | — | — | WO | claimed |
| WO-2020150499-A1 | METHODS TO TAG AND ISOLATE CELLS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2020-07-23 | — | — | WO | claimed |
| WO-2019027834-A1 | COMPOSITIONS AND METHOD FOR ESTABLISHING ORGANOID CULTURES FROM CRYOGENICALLY PRESERVED TISSUE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2019-02-07 | — | — | WO | claimed |
| EP-3071027-A1 | ASSAY-READY FROZEN CELL AND METHOD FOR MINIMIZING VARIABILITY IN THE PERFORMANCE THEREOF | Centre National de la Recherche Scientifique (C.N.R.S.) (FR) | 2016-09-28 | — | — | EP | claimed |
| WO-2015077523-A1 | ASSAY-READY FROZEN CELL AND METHOD FOR MINIMIZING VARIABILITY IN THE PERFORMANCE THEREOF | LE CENTRE NATIONALE DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2015-05-28 | — | — | WO | claimed |
| US-5415870-A | Layers of acid, alkali carbonate and alkali metal salt of acid | Gergely, Gerhard (AT) | 1995-05-16 | — | — | US | claimed |
| JP-58092622-A | — | — | None | — | — | JP | disclosed |
| EP-4303228-B1 | LONG-ACTING COAGULATION FACTOR VII AND METHODS OF PRODUCING SAME | OPKO BIOLOGICS LTD (IL) | 2026-05-27 | — | — | EP | disclosed |
| US-12516130-B2 | Single-domain antibody for targeting prostate specific membrane antigen (PSMA) | NATIONAL INSTITUTE OF BIOTECHNOLOGY IN THE NEGEV LTD. (IL) | 2026-01-06 | — | — | US | disclosed |
| US-12459982-B2 | Methods of producing long acting CTP-modified growth hormone polypeptides | OPKO BIOLOGISTICS LTD. (IL) | 2025-11-04 | — | — | US | disclosed |
| EP-3681511-B1 | COMPOSITION AND METHOD FOR A PREBIOTIC DELIVERY SYSTEM TARGETED TO PROBIOTIC BACTERIA | TECHNION RES & DEV FOUNDATION (IL) | 2025-10-29 | — | — | EP | disclosed |
| US-12391944-B2 | Magnetic inorganic iron-based nanoparticles | BAR-ILAN UNIVERSITY (IL) | 2025-08-19 | — | — | US | disclosed |
| WO-1998023611-A1 | 2-IMIDAZOLINYLAMINOBENZOXAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| WO-1998023610-A1 | 2-IMIDAZOLINYLAMINOINDOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| WO-1998023612-A1 | 2-IMIDAZOLINYLAMINOBENZOTHIAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| WO-1998023596-A1 | GUANIDINYL HETEROCYCLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| WO-1998023591-A1 | GUANIDINYLAMINO HETEROCYCLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| WO-1998023609-A1 | 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 1998-06-04 | — | — | WO | disclosed |
| JP-S5892622-A | PHARMACEUTICAL PREPARATION CONTAINING STABLY COMPOUNDED INTERFERON | SUNSTAR INC | 1983-06-02 | — | — | JP | disclosed |